Biotechnology Company Completes Offerings of Common Stock

A clinical-stage biotechnology company completed several registered underwritten offerings of common stock and warrants, including an "at-the-market" facility. Our firm represented the company in the transactions.

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.